Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity

The chromatin-associated protein WDR5 is a promising target for pharmacological inhibition in cancer. Drug discovery efforts center on the blockade of the “WIN site” of WDR5, a well-defined pocket that is amenable to small molecule inhibition. Various cancer contexts have been proposed to be targets...

Descripción completa

Detalles Bibliográficos
Autores principales: Aho, Erin R., Wang, Jing, Gogliotti, Rocco D., Howard, Gregory C., Phan, Jason, Acharya, Pankaj, Macdonald, Jonathan D., Cheng, Ken, Lorey, Shelly L., Lu, Bin, Wenzel, Sabine, Foshage, Audra M., Alvarado, Joseph, Wang, Feng, Shaw, J. Grace, Zhao, Bin, Weissmiller, April M., Thomas, Lance R., Vakoc, Christopher R., Hall, Matthew D., Hiebert, Scott W., Liu, Qi, Stauffer, Shaun R., Fesik, Stephen W., Tansey, William P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448596/
https://www.ncbi.nlm.nih.gov/pubmed/30865883
http://dx.doi.org/10.1016/j.celrep.2019.02.047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448596/
https://www.ncbi.nlm.nih.gov/pubmed/30865883
http://dx.doi.org/10.1016/j.celrep.2019.02.047

Ejemplares similares